BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30209800)

  • 1. The polycystic ovary syndrome: a position statement from the Polish Society of Endocrinology, the Polish Society of Gynaecologists and Obstetricians, and the Polish Society of Gynaecological Endocrinology.
    Milewicz A; Kudła M; Spaczyński RZ; Dębski R; Męczekalski B; Wielgoś M; Ruchała M; Małecka-Tendera E; Kos-Kudła B; Jędrzejuk D; Zachurzok A
    Endokrynol Pol; 2018; 69(4):. PubMed ID: 30209800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature.
    Azziz R
    J Clin Endocrinol Metab; 2006 Mar; 91(3):781-5. PubMed ID: 16418211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is polycystic ovary syndrome appropriately diagnosed by obstetricians and gynaecologists across China: a nationwide survey.
    Yan D; Yan-Fang W; Shi-Yang Z; Rui-Lin M; Xue-Song D; Xiao M; Wei X; Aijun S
    J Ovarian Res; 2021 Feb; 14(1):25. PubMed ID: 33536040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Progress in gynecological endocrinology].
    Skałba P
    Ginekol Pol; 2008 Dec; 79(12):877-81. PubMed ID: 19175047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do Different Diagnostic Criteria Impact Polycystic Ovary Syndrome Diagnosis for Adolescents?
    Akgül S; Düzçeker Y; Kanbur N; Derman O
    J Pediatr Adolesc Gynecol; 2018 Jun; 31(3):258-262. PubMed ID: 29233731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
    Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
    Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume.
    Lujan ME; Jarrett BY; Brooks ED; Reines JK; Peppin AK; Muhn N; Haider E; Pierson RA; Chizen DR
    Hum Reprod; 2013 May; 28(5):1361-8. PubMed ID: 23503943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.
    Azziz R; Carmina E; Dewailly D; Diamanti-Kandarakis E; Escobar-Morreale HF; Futterweit W; Janssen OE; Legro RS; Norman RJ; Taylor AE; Witchel SF;
    Fertil Steril; 2009 Feb; 91(2):456-88. PubMed ID: 18950759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline.
    Legro RS; Arslanian SA; Ehrmann DA; Hoeger KM; Murad MH; Pasquali R; Welt CK;
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4565-92. PubMed ID: 24151290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
    Parahuleva N; Pehlivanov B; Orbecova M; Uchikova E; Ivancheva H
    Akush Ginekol (Sofiia); 2014; 53(5):22-7. PubMed ID: 25558667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis.
    Bozdag G; Mumusoglu S; Zengin D; Karabulut E; Yildiz BO
    Hum Reprod; 2016 Dec; 31(12):2841-2855. PubMed ID: 27664216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria.
    Franks S
    J Clin Endocrinol Metab; 2006 Mar; 91(3):786-9. PubMed ID: 16418209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rotterdam consensus in adolescent girls: which investigations and how to interpret them to make the diagnosis of PCOS?].
    Reyss AC; Proust-Richard C; Catteau-Jonard S; Dewailly D
    Gynecol Obstet Fertil; 2006 Apr; 34(4):341-6. PubMed ID: 16630737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of clinical and hormonal characteristics among four phenotypes of polycystic ovary syndrome based on the Rotterdam criteria.
    Jamil AS; Alalaf SK; Al-Tawil NG; Al-Shawaf T
    Arch Gynecol Obstet; 2016 Feb; 293(2):447-56. PubMed ID: 26408006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria.
    Yildiz BO; Bozdag G; Yapici Z; Esinler I; Yarali H
    Hum Reprod; 2012 Oct; 27(10):3067-73. PubMed ID: 22777527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype.
    Legro RS; Chiu P; Kunselman AR; Bentley CM; Dodson WC; Dunaif A
    J Clin Endocrinol Metab; 2005 May; 90(5):2571-9. PubMed ID: 15713728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of polycystic ovary syndrome: from NIH criteria to ESHRE-ASRM guidelines.
    Carmina E
    Minerva Ginecol; 2004 Feb; 56(1):1-6. PubMed ID: 14973405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polycystic Ovary Syndrome among Obese Adolescents.
    Ybarra M; Franco RR; Cominato L; Sampaio RB; Sucena da Rocha SM; Damiani D
    Gynecol Endocrinol; 2018 Jan; 34(1):45-48. PubMed ID: 28758509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostics of polycystic ovary syndrome].
    Lazúrová I; Figurová J; Lazúrová Z
    Vnitr Lek; 2015 Dec; 61(12 Suppl 5):5S40-4. PubMed ID: 27124971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H; Tanir HM; Yildiz Z
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.